Peptide K3D/K7D /K10D/K14D/K22D
General Information
DRACP ID DRACP00418
Peptide Name Peptide K3D/K7D /K10D/K14D/K22D
Sequence KWkSFLkTFkSLKkTVLHTLLkAISS
Sequence Length 26
UniProt ID Not available
PubChem CID Not available
Origin Acetylation
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=20.41±0.64 µmol/L | MTS assay | 1 h | 1 |
Hemolytic Activity Human red blood cells: MHC> 325.20 μmol/L
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Chiral Mix
Physicochemical Information
Formula C115H172N26O24
Absent amino acids CDEGMNPQRY
Common amino acids L
Mass 274888
Pl 10.81
Basic residues 3
Acidic residues 0
Hydrophobic residues 11
Net charge 3
Boman Index 659
Hydrophobicity 68.85
Aliphatic Index 105
Half Life
/
Extinction Coefficient cystines 5500
Absorbance 280nm 220
Polar residues 7
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22837667
Title Role of helicity on the anticancer mechanism of action of cationic-helical peptides
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available